[PDF] Top 20 Development and evaluation of ranitidine hydrochloride floating matrix tablet

... From the data (Table No.5) it was found that A1 (15% HPMC K4M & 10% HPMC K15M), A2(20% HPMC K4M & 10% HPMC K15M),A3 ( 20% HPMC K4M &15% HPMC K15M), were unable to sustain drug release for desired time period ... See full document

... as tablet binder (2-5% w/v), emulsifier, rate controlling polymer, stabilizing agent in gels, adhesive in plastic bandages, suspending agent, thickening agent ... See full document

... In vitro dissolution studies were performed for all the formulation combinations in dissolution apparatus. An accurately weighed sample (50 mg) of floating alginate bead formulations was dropped into 900 ml of HCl ... See full document

... Floating matrix tablets of metformin hydrochloride were developed and evaluated for increase bioavailability by increasing gastric residence time and sustained release of drug on the upper part of ... See full document

... Aspirin is rapidly absorbed in the stomach and upper intestine. The oral bioavailability of regular aspirin tablets is approximately 40-50% over a wide range of dose. A considerably lower bioavailability has been ... See full document

... The present work was aim to formulate effervescent floating matrix tablets of Pentoxifylline as gastro retentive drug delivery system. Rapid gastrointestinal transit could result in incomplete drug release ... See full document

... ABSTRACT: Floating matrix tablets of ranitidine hydrochloride were developed and evaluated to increase bioavailability by increasing gastric residence time and sustained release of drug in the ... See full document

... effevescent floating matrix formulation of Gliclazide were formulated by using various hydrophilic ...method development was done for the drug ... See full document

... Formulation development was carried out using different concentrations of HPMC K15 polymer, PVP and excipients added, all together 4 formulations are carried ... See full document

... fine floating tablets of the combination of the two and investigate the possibility of those tablets as a delivery system for controlled release of ondansetron and immediate release of ...the development of ... See full document

... of ranitidine is 150 mg twice daily or 300 mg once ...of ranitidine 4 times a day ...of Ranitidine HCl is desirable ...favors development of a sustained-release ...tract. Ranitidine is ... See full document

... This floating dosage form is well known as a hydrodynamically balanced system ...[3]. Floating tablets, capsules, beads, microspheres and chambers have been reported in literature ... See full document

... the development of sustained release (SR) or controlled release (CR) drug delivery ...Eperisone hydrochloride is a centrally acting muscle relaxant acting through poly and mono-synaptic reflexes in the ... See full document

... These considerations have led to the development of a control or sustain delivery system. Sustained delivery describes drug delivery system with delayed and/or prolonged release of drug. 1 Sustained release ... See full document

... acid and forms hydrogel in water or alkaline solution due to hydration of the carboxyl groups in its structure. For drugs that are primarily released in the acidic region of the gastrointestinal tract (GIT), carbopol 940 ... See full document

... bilayered floating tablets of Ranitidine HCl and Levofloxacin can be ...of Ranitidine HCl and Levofloxacin floating tablets as oral controlled drug delivery ...on floating and release ... See full document

... of tablet hardness was the friability. Compressed tablets that lose less than 1 % of their weight are generally considered acceptable. For all formulation tried here the weight loss was less than 1 % hence ... See full document

... wall matrix and cellular proliferation resulting in vascular complications like lumen narrowing, early atherosclerosis, sclerosis of glomerullar capillaries, retinopathy, neuropathy and peripheral vascular ... See full document

... called Floating drug delivery system (FDDS) is an oral dosage form (capsule or tablet) designed to prolong the residence time of the dosage form within the ... See full document

... .Ranitidine hydrochloride is a histamine H2-receptor ...of ranitidine is 150 mg twice daily or 300 mg once ...of ranitidine 4 times a ...favors development of a controlled release ... See full document